GEAR UNIVERSITYLoading…
AVERY FISK · AF COACHING

Androgens

Dimethazine

A linked steroid molecule whose experimental breakdown and metabolites overlap with methasterone.

Human-liver/mouse metabolism models plus a combination-product case report; evidence checked 2026-10-01

Also known as: Dymethazine · DMZ

Dimethazine molecular structure
Structure reference · C42H68N2O2

Practical use

Evidence interpretation and concrete review questions

List every active ingredient
A brand-level adverse event may involve multiple steroids.
Preserve timing
Record exposure and symptom dates for a clinician.
Recognize concerning symptoms
Yellowing eyes, dark urine or substantial itching deserve prompt medical assessment.

Dimethazine metabolism

PubChem chemical identity; checked October 1, 2026

Additional primary or official source

Overview

Dimethazine, also spelled dymethazine, consists of two methasterone units connected through an azine group. The linkage does not make it a nutrient or establish that it avoids the biological concerns of its related steroid.

Risks and limitations

A human cholestatic-jaundice report involved a product containing both dimethazine and methylstenbolone. It is a real clinical warning but cannot assign the injury solely to either ingredient.

How to read this

Product mixtures and metabolic breakdown both complicate attempts to attribute a benefit or adverse event to one name.

Research explained

Dimethazine metabolism

Who was studied

Human liver microsomes and mice with humanized liver tissue used to investigate a dimethazine product.

What was found

Dimethazine degraded to methasterone in stability work. Methasterone and six additional metabolites associated with it were detected in the experimental systems.

What it cannot establish

Humanized mice and microsomes are not a human safety trial; chemical overlap cannot establish identical clinical exposure.

Read the original study

Two linked units do not stay a marketing concept

Observed breakdown to methasterone gives a concrete reason to examine the actual chemistry.

Supporting source

A combination injury has attribution limits

A 26-year-old man developed cholestatic jaundice after a product containing dimethazine and methylstenbolone.

Supporting source

Claims versus findings

Not established

A linked dimer has been proved safer than methasterone.

The metabolism study did not compare clinical safety.

Check the evidence

Common questions

Can the combination case identify one guilty ingredient?

No. It supports concern about the product exposure without isolating a single molecule.

Source

Sources

Dimethazine metabolism

PubChem chemical identity; checked October 1, 2026

Additional primary or official source

Sources checked 2026-10-01.

General education; not a personal treatment plan.